ValSource Viewpoints

ValSource Viewpoints

By ValSourceScience
Download on the App Store

ValSource Viewpoints episodes

  • Building an Effective and Engaged Safety Culture in the Construction Industry

    This episode is the first of a new safety-focused series.

    ValSource Senior Safety Consultant Art

    Limper, known for his career enhancing safety protocols and promoting best practices across all aspects of pharmaceutical manufacturing and operations, discusses what it takes to create a successful safety program.
    Art has been a key contributor to ValSource Safety
    Solutions, a comprehensive program combining ValSource consulting services and resources with PIMSHQ’s innovative PIMS Safety software. 

     

    18 min
  • Reflections on the 2024 PDA Annual Meeting

    ValSource Director of Learning Jim Vesper, PhD, and Senior Consultant Amanda McFarland, join PDA Chief of Staff Tita Tavares to discuss their reflections on the 2024 PDA Annual Meeting. Topics covered include new additions to the format, favorite sessions, and the overarching theme of innovation.

    16 min
  • Updates to ICH Q9 R1: Quality Risk Management Guidelines

    Important Announcement — The International Council for Harmonization (ICH) issued a revision of the Q9 guideline for risk management. ValSource consultants specialize in risk management. Tune into our new podcast to hear from three of them — Amanda McFarland, M.Sc. Senior Consultant, Beth Fulton, M.S. QRM Consultant, and Patrick Mains, PMP, Senior Consultant as they discuss significant changes that are in the R1 version of Q9.


    19 min
  • ATMP/CGT Contamination Control Strategies

    This is the 5th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that include cell and gene therapies. Specifically, we'll be discussing ATMP/CGT and Contamination Control strategies.

    To learn more about how ValSource can support you, visit www.valsource.com

    17 min
  • ATMPs: Third Parties

    In the 4th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that include cell and gene therapies, we'll be discussing ATMP/CGT and working with third parties.

    To learn more about how ValSource can support you, visit www.valsource.com

    24 min
  • ATMPs: Regulations and Expectations

    Continue the ATMP discussion with our experts. This episode is focused on working with third parties, what regulations and expectations are out there now, and what might be coming around the corner.

    To learn more about how ValSource can support you, visit www.valsource.com

    32 min

About ValSource Viewpoints

From the publisher's feed

Tune in to our podcast as ValSource experts explore the latest developments and insights within pharmaceutical, advanced therapy medicinal products, biologics and medical device regulated industries.